Cargando...
Targeting Glutamatergic Signaling and the PI3 Kinase Pathway to Halt Melanoma Progression()()
Our group has previously reported that the majority of human melanomas (> 60%) express the metabotropic glutamate receptor 1 (GRM1) and that the glutamate release inhibitor riluzole, a drug currently used to treat amyotrophic lateral sclerosis, can induce apoptosis in GRM1-expressing melanoma cel...
Guardado en:
| Publicado en: | Transl Oncol |
|---|---|
| Autores principales: | , , , , , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Neoplasia Press
2015
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4350641/ https://ncbi.nlm.nih.gov/pubmed/25749171 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tranon.2014.11.001 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|